Literature DB >> 167149

Dose-response relationships for arginine vasopressin and synthetic analogs on three types of rat blood vessels: possible evidence for regional differences in vasopressin receptor sites within a mammal.

B M Altura.   

Abstract

These experiments were undertaken to determine the comparative relationships between chemical structure and biologic (contractile) activity of a series of vasopressin hormone analogs on different rat blood vessels (e.g., aorta, mesenteric arteriole and mesenteric venule). The functional contributions to, and interactions with, phenolic hydroxyl and aromatic groups as well as basicity in positions 2, 3 and 8, respectively, to or with hormone-receptor affinity and intrinsic (contractile) activity, were determined by analyzing the dose-response curves of five vasopressin peptides lacking one or more of these functional groups. The findings demonstrate that: 1) the structure-action relationships for vasopressin peptide-induced contractions on rat blood vessels vary with the particular type of macro- or microvessel (i.e., aorta, arteriole and venule); 2) the phenolic and aromatic groups in positions 2 and 3, respectively, are not only important for hormone-receptor affinity but intrinsic activity as well; 3) the potency (EC50) values for arginine vasopressin as well as the potencies and intrinsic activities of synthetic vasopressin analogs varied between the three different types of rat blood vessels examined; and 4) circulating levels (i.e., 10- minus 11- minus 10- minus 12 M) of [8-arginine]-vasopressin are capable of inducing contractile effects on mesenteric arterioles and venules. The quantitative data obtained in this study support the notion that a heterogeneity of the receptor, which subserves contraction, probably exists in blood vessels within and between vascular beds of a single mammalian species.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 167149

Source DB:  PubMed          Journal:  J Pharmacol Exp Ther        ISSN: 0022-3565            Impact factor:   4.030


  11 in total

1.  Vasopressin-induced vasoconstriction: two concentration-dependent signaling pathways.

Authors:  Kyle K Henderson; Kenneth L Byron
Journal:  J Appl Physiol (1985)       Date:  2007-01-04

2.  Exploring arterial smooth muscle Kv7 potassium channel function using patch clamp electrophysiology and pressure myography.

Authors:  Lioubov I Brueggemann; Bharath K Mani; Jennifer Haick; Kenneth L Byron
Journal:  J Vis Exp       Date:  2012-09-14       Impact factor: 1.355

3.  Hemodynamic changes of systemic, hepatic, and splenic circulation following triglycyl-lysin-vasopressin administration in alcoholic cirrhosis.

Authors:  C Merkel; A Gatta; M Bolognesi; G Finucci; G Battaglia; P Angeli; R Zuin
Journal:  Dig Dis Sci       Date:  1988-09       Impact factor: 3.199

4.  Endothelium-dependent modulation of the pressor activity of arginine vasopressin in the isolated superior mesenteric arterial bed of the rat.

Authors:  M D Randall; A P Kay; C R Hiley
Journal:  Br J Pharmacol       Date:  1988-10       Impact factor: 8.739

5.  Hyperammonaemia in V1a vasopressin receptor knockout mice caused by the promoted proteolysis and reduced intrahepatic blood volume.

Authors:  Masami Hiroyama; Toshinori Aoyagi; Yoko Fujiwara; Sayuri Oshikawa; Atsushi Sanbe; Fumio Endo; Akito Tanoue
Journal:  J Physiol       Date:  2007-03-22       Impact factor: 5.182

6.  Vascular KCNQ potassium channels as novel targets for the control of mesenteric artery constriction by vasopressin, based on studies in single cells, pressurized arteries, and in vivo measurements of mesenteric vascular resistance.

Authors:  Alexander R Mackie; Lioubov I Brueggemann; Kyle K Henderson; Aaron J Shiels; Leanne L Cribbs; Karie E Scrogin; Kenneth L Byron
Journal:  J Pharmacol Exp Ther       Date:  2008-02-13       Impact factor: 4.030

7.  Biochemical and pharmacological properties of SR 49059, a new, potent, nonpeptide antagonist of rat and human vasopressin V1a receptors.

Authors:  C Serradeil-Le Gal; J Wagnon; C Garcia; C Lacour; P Guiraudou; B Christophe; G Villanova; D Nisato; J P Maffrand; G Le Fur
Journal:  J Clin Invest       Date:  1993-07       Impact factor: 14.808

8.  Relaxation of human isolated mesenteric arteries by vasopressin and desmopressin.

Authors:  M C Martínez; J M Vila; M Aldasoro; P Medina; B Flor; S Lluch
Journal:  Br J Pharmacol       Date:  1994-10       Impact factor: 8.739

9.  Stimulation of inorganic-phosphate incorporation into phosphatidylinositol in rat thoracic aorta mediated through V1-vasopressin receptors.

Authors:  A P Takhar; C J Kirk
Journal:  Biochem J       Date:  1981-01-15       Impact factor: 3.857

Review 10.  Clinical review: Vasopressin and terlipressin in septic shock patients.

Authors:  Anne Delmas; Marc Leone; Sébastien Rousseau; Jacques Albanèse; Claude Martin
Journal:  Crit Care       Date:  2004-09-09       Impact factor: 9.097

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.